Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The latest update is out from SeaStar Medical Holding ( (ICU) ).
On June 6, 2025, SeaStar Medical Holding Corporation announced that its CEO, Mr. Eric Schlorff, and CMO, Dr. Kevin Chung, have agreed to waive their earned bonuses for the fiscal years 2023 and 2024. This decision is part of the company’s efforts to reduce liabilities, potentially impacting its financial stability and demonstrating a commitment to fiscal responsibility.
The most recent analyst rating on (ICU) stock is a Buy with a $18.00 price target. To see the full list of analyst forecasts on SeaStar Medical Holding stock, see the ICU Stock Forecast page.
Spark’s Take on ICU Stock
According to Spark, TipRanks’ AI Analyst, ICU is a Underperform.
SeaStar Medical Holding faces significant financial challenges, with negative equity and reliance on external financing posing risks to its financial health. Technical indicators show bearish momentum, and valuation metrics highlight ongoing losses, contributing to a low overall stock score.
To see Spark’s full report on ICU stock, click here.
More about SeaStar Medical Holding
Average Trading Volume: 170,219
Technical Sentiment Signal: Sell
Current Market Cap: $12.94M
Find detailed analytics on ICU stock on TipRanks’ Stock Analysis page.